295 results on '"Lemanski, Claire"'
Search Results
2. A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers
3. Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASE
4. Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial
5. Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE
6. Comparison of short course radiotherapy with chemoradiotherapy for locally advanced rectal cancers in the elderly: A multicentre, randomised, non-blinded, phase 3 trial
7. Interventions non médicamenteuses et cancer du sein : quel bénéfice en complément d’une radiothérapie ?
8. Prognostic Value of 18F-FDG PET/CT Assessment After Radiotherapy of Squamous Cell Carcinoma of the Anus in Patients from the National Multicentric Cohort FFCD-ANABASE.
9. Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity Score-Matched Cohort Analysis of the GEC-ESTRO Breast Cancer Working Group Database
10. What is the optimal treatment for T1N0 anal squamous cell carcinoma? Analysis of current practices in the prospective French FFCD ANABASE cohort
11. Ductal Carcinoma in Situ: A French National Survey. Analysis of 2125 Patients
12. Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective study
13. Anti-epidermal growth factor receptor therapy in combination with chemoradiotherapy for the treatment of locally advanced anal canal carcinoma: Results of a phase I dose-escalation study with panitumumab (FFCD 0904)
14. Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03)
15. Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial
16. Intraoperative Technique with Electrons
17. GRECCAR 14 – a multicentric, randomized, phase II–III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol.
18. Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy
19. Factors associated with patient-reported cosmetic outcome in the Young Boost Breast Trial
20. Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer
21. Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management
22. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: Long term results of an ISIORT pooled analysis
23. Role of Brachytherapy in the Boost Management of Anal Carcinoma With Node Involvement (CORS-03 Study)
24. Breast cancer occurred after Hodgkin's disease: Clinico-pathological features, treatments and outcome: Analysis of 214 cases
25. Liste des auteurs
26. Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ
27. Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial
28. Intraoperative Radiotherapy in Early-Stage Breast Cancer: Results of the Montpellier Phase II Trial
29. Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors
30. Radiochemotherapy of locally advanced anal canal carcinoma: Prospective assessment of early impact on the quality of life (randomized trial ACCORD 03)
31. Cancer du sein in situ
32. MRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma
33. Effectiveness of Prophylactic Gastrostomy in Head and Neck Cancer Patients Treated by Image-Guided Radiotherapy and Chemotherapy: Practice Proposal by the International Geriatric Radiotherapy Group
34. Effectiveness of the Cough Reflex in Patients with Aspiration Following Radiation for Head and Neck Cancer
35. Impact of swallowing therapy on aspiration rate following treatment for locally advanced head and neck cancer
36. Concurrent chemoradiation for locally advanced oropharyngeal cancer
37. Outcome and prognostic factors in breast sarcoma: A multicenter study from the rare cancer network
38. Surgery for Esophageal Cancer after Concomitant Radiochemotherapy: Oncologic and Functional Results
39. Sphincter‐saving surgery for ultra‐low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long‐term follow‐up?
40. Restorative and Nonrestorative Surgery for Low Rectal Cancer After High-Dose Radiation: Long-Term Oncologic and Functional Results
41. Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation
42. Dysphagia severity following chemoradiation and postoperative radiation for head and neck cancer
43. Aspiration rate following chemoradiation for head and neck cancer: An underreported occurrence
44. The actual benefit of intraoperative radiation therapy using 50 kV x‐rays in early breast cancer: A retrospective study of 676 patients
45. Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure
46. Phase III Randomized Trial of Very Accelerated Radiation Therapy Compared With Conventional Radiation Therapy in Squamous Cell Head and Neck Cancer: A GORTEC Trial
47. Dosimetric comparison between coplanar and non coplanar field radiotherapy for ethmoid sinus cancer
48. Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans
49. IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center
50. Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.